Fleming Initiative and Cepheid Launch Landmark Study of Rapid Testing for Drug-Resistant Infections

▤ Summary

Cepheid and the Fleming Initiative have launched TRACE-CPE, a 30-month real-world study across two London NHS Trusts. The project will compare rapid molecular screening for carbapenemase-producing Enterobacterales against slower culture-based methods. The study will measure effects on infection control, patient outcomes, costs, and NHS workflow efficiency. Its findings should help hospitals and policymakers decide how to deploy rapid diagnostics more broadly across the NHS and similar health systems.

▦ Linked Companies

Cepheid

$100M to $250M